[HTML][HTML] Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress

X Wu, J Jiang, Z Gu, J Zhang, Y Chen, X Liu - Stem cell research & …, 2020 - Springer
Mesenchymal stromal cells (MSCs) are a subset of heterogeneous non-hematopoietic
fibroblast-like cells that can differentiate into cells of multiple lineages, such as …

[HTML][HTML] Characteristics and therapeutic potential of human amnion-derived stem cells

QW Liu, QM Huang, HY Wu, GSL Zuo, HC Gu… - International journal of …, 2021 - mdpi.com
Stem cells including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
and adult stem cells (ASCs) are able to repair/replace damaged or degenerative tissues and …

[HTML][HTML] Application of human amniotic epithelial cells in regenerative medicine: a systematic review

Q Zhang, D Lai - Stem cell research & therapy, 2020 - Springer
Human amniotic epithelial cells (hAECs) derived from placental tissues have gained
considerable attention in the field of regenerative medicine. hAECs possess embryonic stem …

[HTML][HTML] Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities

YX Fu, J Ji, F Shan, J Li, R Hu - Stem Cell Research & Therapy, 2021 - Springer
Premature ovarian failure (POF) is one of the common disorders found in women leading to
1% female infertility. Clinical features of POF are hypoestrogenism or estrogen deficiency …

3D bioprinting and in vitro study of bilayered membranous construct with human cells-laden alginate/gelatin composite hydrogels

P Liu, H Shen, Y Zhi, J Si, J Shi, L Guo… - Colloids and Surfaces B …, 2019 - Elsevier
Extrusion-based 3D bioprinting of cell-laden hydrogels is a potential technology for
regenerative medicine, which enables the fabrication of constructs with spatially defined cell …

[HTML][HTML] Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes

F Lebreton, V Lavallard, K Bellofatto, R Bonnet… - Nature …, 2019 - nature.com
Maintaining long-term euglycemia after intraportal islet transplantation is hampered by the
considerable islet loss in the peri-transplant period attributed to inflammation, ischemia and …

[HTML][HTML] From grafts to human bioengineered vascularized skin substitutes

W Oualla-Bachiri, A Fernández-González… - International journal of …, 2020 - mdpi.com
The skin plays an important role in the maintenance of the human's body physiological
homeostasis. It acts as a coverage that protects against infective microorganism or …

[HTML][HTML] Bio-engineering of pre-vascularized islet organoids for the treatment of type 1 diabetes

CH Wassmer, F Lebreton, K Bellofatto… - Transplant …, 2022 - frontierspartnerships.org
Lack of rapid revascularization and inflammatory attacks at the site of transplantation
contribute to impaired islet engraftment and suboptimal metabolic control after clinical islet …

[HTML][HTML] Organ-on-chip technology: the future of feto-maternal interface research?

L Richardson, S Kim, R Menon, A Han - Frontiers in Physiology, 2020 - frontiersin.org
The placenta and fetal membrane act as a protective barrier throughout pregnancy while
maintaining communication and nutrient exchange between the baby and the mother …

Copper-containing mesoporous bioactive glass promotes angiogenesis in an in vivo zebrafish model

LB Romero-Sánchez, M Marí-Beffa, P Carrillo… - Acta biomaterialia, 2018 - Elsevier
The osteogenic and angiogenic responses of organisms to the ionic products of degradation
of bioactive glasses (BGs) are being intensively investigated. The promotion of …